Capital Performance Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,934
Closed -$107K 2072
2024
Q3
$107K Buy
+1,934
New +$107K 0.03% 186